This Article Full Text (PDF) All Versions of this Article: 1352458507076970v1 13/7/884    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Soon, D. Articles by Miller, D. Search for Related Content PubMed PubMed Citation Articles by Soon, D. Articles by Miller, D. Social Bookmarking                         What's this?

Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes

NMR Research Unit, Department of Neuroinflammation, Institute of Neurology, University College London, London, UK

DJ Tozer

NMR Research Unit, Department of Neuroinflammation, Institute of Neurology, University College London, London, UK

DR Altmann

NMR Research Unit, Department of Neuroinflammation, Institute of Neurology, University College London, London, UK

PS Tofts

NMR Research Unit, Department of Neuroinflammation, Institute of Neurology, University College London, London, UK

DH Miller

NMR Research Unit, Department of Neuroinflammation, Institute of Neurology, University College London, London, UK, d.miller{at}ion.ucl.ac.uk

Few attempts have been made to detect subtle blood-brain barrier (BBB) leakage in visibly non-enhancing MRI lesions in multiple sclerosis (MS). For 19 patients, longitudinal relaxation time (T1) maps were generated from MRI scans obtained before, and at 20, 40 and 60 minutes after injection of gadolinium (Gd)-DTPA (0.3 mmol/kg). Regions of interest (ROI) were placed around non-enhancing lesions, and in paired contralateral normal appearing brain tissue (NABT). Post-Gd rate of R1 (=1/T1) rise (R1/t), was used to quantify leakage. R1/t was greater in lesions than paired NABT (P 0.001 at all post-Gd timepoints). R1/t was greater in T1 hypointense than isointense lesions (P = 0.001 and 0.01 for first and second timepoints respectively), and negatively related to lesion cross sectional area (P 0.001 at all post-Gd timepoints). Relapsing remitting (RRMS) lesions had a greater initial R1/t than secondary progressive (SPMS) lesions ( P = 0.04), but this was not seen in subsequent timepoints. R1/t in visibly enhancing lesions was significantly greater than in visibly non-enhancing lesions, with no overlap in the normal ranges of the two populations. Subtle BBB leakage is a consistent feature in non-enhancing lesions, and is distinct from the overt BBB leakage observed in visibly enhancing lesions. It is detectable using quantitative contrast-enhanced MRI. It is apparent in all clinical and lesion subtypes studied, and greater in T1 hypointense and smaller lesions. Larger initial R1/t in RRMS than SPMS lesions may reflect differences in blood volume rather than BBB leakage. Multiple Sclerosis 2007; 13: 884—894. http://msj.sagepub.com

Key Words: blood brain barrier • multiple sclerosis • non-enhancing lesions • T1 maps

This version was published on August 1, 2007

Multiple Sclerosis, Vol. 13, No. 7, 884-894 (2007)
DOI: 10.1177/1352458507076970


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?